Insider · CIK 0001665430

EMPFIELD JAMES R.

Reports to the SEC for 1 company · BURNABY, A1

sec.gov

Transactions

Companies

Filings

CIK

0001665430

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-11	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+65K sh	—	—	65,000
2023-03-10	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+75K sh	—	—	75,000
2022-08-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	+20K sh	$3.10	+$62K	30,000
2022-08-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	+45K sh	$4.75	+$214K	75,000
2022-08-12	XENEXenon Pharmaceuticals Inc.F Tax Payment	EVP, Drug Discovery	FTax Payment	−7,257 sh	$38.02	−$276K	67,743
2022-08-12	XENEXenon Pharmaceuticals Inc.S Sale	EVP, Drug Discovery	SSale	−35.9K sh	$38.08	−$1.37M	31,875
2022-08-12	XENEXenon Pharmaceuticals Inc.S Sale	EVP, Drug Discovery	SSale	−21.9K sh	$38.68	−$846K	10,000
2022-08-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	−20K sh	—	—	0
2022-08-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	−45K sh	—	—	0
2022-03-10	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+65K sh	—	—	65,000
2022-03-07	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	+2,500 sh	$8.40	+$21K	12,500
2022-03-07	XENEXenon Pharmaceuticals Inc.F Tax Payment	EVP, Drug Discovery	FTax Payment	−695 sh	$30.23	−$21K	11,805
2022-03-07	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	+40K sh	$6.76	+$270K	51,805
2022-03-07	XENEXenon Pharmaceuticals Inc.F Tax Payment	EVP, Drug Discovery	FTax Payment	−8,952 sh	$30.23	−$271K	42,853
2022-03-07	XENEXenon Pharmaceuticals Inc.S Sale	EVP, Drug Discovery	SSale	−1,805 sh	$30.62	−$55.3K	41,048
2022-03-07	XENEXenon Pharmaceuticals Inc.S Sale	EVP, Drug Discovery	SSale	−31K sh	$30.54	−$948K	10,000
2022-03-07	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	−2,500 sh	—	—	0
2022-03-07	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	−40K sh	—	—	0
2022-03-04	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	+25K sh	$8.40	+$210K	35,000
2022-03-04	XENEXenon Pharmaceuticals Inc.F Tax Payment	EVP, Drug Discovery	FTax Payment	−6,685 sh	$31.42	−$210K	28,315
2022-03-04	XENEXenon Pharmaceuticals Inc.S Sale	EVP, Drug Discovery	SSale	−18.3K sh	$30.79	−$564K	10,000
2022-03-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Drug Discovery	MExercise/Conversion	−25K sh	—	—	0
2021-03-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+65K sh	—	—	65,000
2020-03-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+65K sh	—	—	65,000
2019-09-16	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+40K sh	—	—	40,000
2018-03-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+45K sh	—	—	45,000
2017-10-23	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+20K sh	—	—	20,000
2017-08-15	XENEXenon Pharmaceuticals Inc.P Purchase	EVP, Drug Discovery	PPurchase	+10K sh	$2.48	+$24.8K	10,000
2017-03-13	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+27.5K sh	—	—	27,500
2016-02-08	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Drug Discovery	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Mar 124
EMPFIELD JAMES R.0000950170-24-030236
SEC(opens sec.gov)
Mar 144
EMPFIELD JAMES R.0001209191-23-018470
SEC(opens sec.gov)
Aug 164
EMPFIELD JAMES R.0001209191-22-046017
SEC(opens sec.gov)
Mar 144
EMPFIELD JAMES R.0001209191-22-018440
SEC(opens sec.gov)
Mar 84
EMPFIELD JAMES R.0001209191-22-017316
SEC(opens sec.gov)

Companies

Xenon Pharmaceuticals Inc.EVP, Drug DiscoveryXENE

Address

C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY

BURNABY, A1, V5G 4W8